CaHA Injectable for Facial Use Gains Regulatory Approval in China
The approval makes it the first calcium hydroxylapatite microsphere injectable product approved in China for facial soft tissue augmentation, according to the company.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
